Skip to content

Wednesday, June 3, 2026

Latest:

Is creatine for you?
CPRIT awards more than $12 million to BCM for cancer research
Ready or not: How to know if your child can handle a sleepover
Polycystic Ovary Syndrome isn’t what you think. A new name makes it clear.
A Traditional Chinese Medicine perspective on seasonal health and nutrition

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

5D4

5D4 disrupts several molecular pathways, including MYC, that lead to cancer growth

October 26, 2023 5D4, Breast Cancer, cancer inhibitor, MYC, ovarian cancer, PARP inhibitor, Research, TopBP1

The findings strongly support the potential use of TopBP1 inhibitors as a targeted cancer therapy.

From the Labs: Image of the Month

From the Labs: Breast cancer cell clusters

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951